Association of White Matter Hyperintensities With Serum Lipid Profile and Hematologic Parameters in Migraine Patients
Abstract
Introduction Migraine is one of the most common neurological diseases. Comorbidities, especially stroke, may be observed. White matter hyperintensities are common in migraine patients. Although many factors have been associated with white matter hyperintensities, such as age, gender, migraine type, frequency, and presence of aura, the etiology of white matter hyperintensities remains unclear. We aimed to study the relationship between the development of white matter hyperintensities and serum lipid profiles and hematologic parameters in migraine patients. Methods Demographic data, comorbidities, migraine types, presence of aura, and frequency of attacks were reviewed. Cranial MRI scans, hematologic profiles, and lipid profiles were analyzed. Results The study included 51 patients with white matter hyperintensity on cranial MRI and 76 migraine patients with normal cranial MRI. High-density lipoprotein cholesterol (HDL-c) was statistically significantly higher in the patients with white matter hyperintensity in the cranial MRI (WMH+) group. A statistically significant cut-off value was found for the PLR parameter in differentiating white matter hyperintensity on cranial MRI in migraine patients. Conclusion In our study, we examined the factors contributing to the development of white matter hyperintensity in migraine patients and observed the correlation between disease duration and white matter hyperintensity. While no correlation was observed between low-density lipoprotein…
How strong is the evidence?
Evidence Hub reads this as a randomized trial, done in people. Its evidence level is 2 of 5 (High · randomized trial). Randomized trials of a reasonable size are the strongest single-study design. Reported size: 76 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.